-
Burberry returns to full-year profit on turnaround plan
-
Spiky, polarising, rarely dull: ups and downs of rugby's Eddie Jones
-
Denmark, Australia in the spotlight in Eurovision second semi
-
Heavy Russian strikes on Kyiv kill one, wound 31
-
Xi warns Trump on Taiwan at Beijing summit
-
Iran war and oil dominate BRICS meet in India
-
Bone appetit: Paris pups lap up treats at dog-centric spots
-
Kohli senses end after roaring back to form with IPL century
-
India bars sugar exports until September
-
Madonna, Shakira, BTS to headline first World Cup final half-time show
-
Japan takes 'half step' toward fixing slow retrial system
-
Honda posts operating loss, first since 1957
-
Madonna, Shakira, BTS to headline World Cup final half-time show
-
A quarter of World Cup games risk searing heat: scientists
-
Six hantavirus cruise passengers head to Australia
-
Suspect detained in Philippine senate gunfire: police
-
Cavs top Pistons in overtime for 3-2 series lead
-
Canadian football ready for World Cup coming out party
-
US court suspends sanctions on UN expert on Palestinians
-
Asia markets mixed as Trump-Xi summit, AI trade dominate
-
'Promised to us': The Israelis dreaming of settling south Lebanon
-
'Rare, meaningful': North Korean football team ventures into South
-
In-form Messi hits brace as Miami win 5-3 at Cincinnati in MLS
-
Historic Swiss solar-powered plane crashes into sea
-
A woman UN leader is 'historical justice,' says Ecuadoran contender for top job
-
Indian pharma fuels Africa's 'zombie drug' and opioid crisis
-
After months of blackout, Iran gives internet to select few
-
Wood urges New Zealand to 'create some history' at World Cup
-
In Washington, the fight to preserve Black cemeteries
-
US children's book author sentenced to life after poisoning husband
-
Emotional Vin Diesel leads 'Fast and Furious' tribute in Cannes
-
PLAS-LABS Simplifies Scientific Validation With Automated Citation Tracking Powered by Bioz
-
Battery X Metals Achieves Milestone with Delivery of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Machine Featuring Design Enhancements, Advancing Strategic Commercialization Initiatives
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 14
-
Akkodis Recognized in HFS Horizons 2026 Report for Enterprise Ready Agentic AI Services
-
Lexus Of Oakville Recognized for Redefining the Luxury Dealership Experience With 2026 Consumer Choice Award
-
US renews offer of $100 mn to Cuba if it cooperates
-
City still 'alive' but need Arsenal slip: Guardiola
-
Man City ease past Palace to keep pressure on Arsenal
-
Alaves end champions Barca's bid for 100-point record
-
US jury begins deliberations on 737 MAX victim suit against Boeing
-
PSG clinch fifth straight Ligue 1 title
-
Inter Milan win Italian Cup to secure domestic double
-
Man City see off Palace to keep pressure on Arsenal
-
Trump and Xi set for high-stakes talks in Beijing
-
S&P 500, Nasdaq end at records as oil prices retreat
-
Iran holds World Cup send-off for national football team
-
McIlroy's toe 'totally fine' after nine-hole PGA practice
-
Rare 'Ocean Dream' blue-green diamond sells for $17 mn at auction
-
California says probing possible violations over World Cup ticket sales
Right-to-die activists on trial in France as lawmakers debate end-of-life bill
Twelve activists accused of helping people in France to illegally obtain a euthanasia drug went on trial in Paris on Monday, as the country debates a right-to-die bill.
The defendants are members of Ultime Liberte (Ultimate Freedom), an association that fights to legalise assisted suicide and euthanasia in France.
They are accused of helping dozens of people purchase pentobarbital, a drug used for physician-assisted suicide in countries such as Belgium and Switzerland, between August 2018 and November 2020.
Many of the defendants, whose ages range from 74 to 89, are retired teachers with no criminal records.
They are charged with trafficking illegal substances and face up to 10 years in prison if convicted, although any sentences are expected to be much more lenient, given mitigating factors including their age.
In France, pentobarbital is only authorised to euthanise animals, while in the United States, the drug is used to carry out executions.
Few countries regulate assisted dying, and in many it remains a crime to help someone end their life, even in cases of severe and incurable suffering.
The debate on assisted dying has raged in France for years.
In May, the lower house of parliament approved a right-to-die bill on first reading, the initial step in a lengthy process that could grant patients medical assistance to end their lives in clearly defined circumstances.
- 'We are satisfied' -
Outside the Paris court, about 70 members of the association rallied in support of the defendants.
"We are satisfied that there is a trial so that we can bring (the issue) to public attention," Monique Denis, the wife of one of the defendants, told AFP.
"And perhaps public opinion will come out in favour of changing the law," the 69-year-old added.
Ultime Liberte's campaign goes beyond the demands of traditional pro-euthanasia associations, advocating for the right for people to control the manner and timing of their death, whether terminally ill or not.
"Suicide has been decriminalised since the Revolution but there are many laws that prevent the freedom to commit suicide, non-violent suicide," Claude Hury, head of Ultime Liberte, told AFP ahead of the trial.
She said her group wanted to help people age peacefully and die with dignity.
"Our goal is not to kill people," Hury said.
"It is to help them continue to age while being very serene about the end, provided they have this magic pill at home so they can stop when they decide to, rather than waiting for the medical diktat."
The investigation began in 2019 following a US report on a network that shipped pentobarbital worldwide in liquid form, disguised in bottles labelled "natural cosmetics".
Armed with a list of buyers provided by US investigators, French authorities carried out around one hundred searches across the country in October 2019.
The buyers were mostly elderly or seriously ill people, though some suicides appeared unrelated to age or illness.
The investigation found that some members of the association accompanied those wishing to die by giving them information on how to order the drug or even helping them obtain it.
By sharing the information only with those who requested it, the activists did not intend to "encourage or facilitate a decision to commit suicide" but rather to "accompany" that decision, said the investigating judge.
One member said he joined the association after a relative used the group to end their life.
"I am here to see if I can help in some way, so that when I'm 80 and ill, I won't have to do it behind closed doors," said the 61-year-old, releasing only his first name, Franck.
France's draft law would allow assisted dying only in an "advanced" stage of illness, which it defines as "entering an irreversible process characterised by a worsening health condition of the sick person that affects the quality of their lives".
If approved, France would join a small group of European countries that give the right to aid in dying, including Austria, Germany, Spain and Switzerland.
The trial is set to conclude on October 9.
A.O.Scott--AT